Product NDC: | 0013-0101 |
Proprietary Name: | Azulfidine |
Non Proprietary Name: | SULFASALAZINE |
Active Ingredient(s): | 500 mg/1 & nbsp; SULFASALAZINE |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0013-0101 |
Labeler Name: | Pharmacia and Upjohn Company |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA007073 |
Marketing Category: | NDA |
Start Marketing Date: | 19500620 |
Package NDC: | 0013-0101-11 |
Package Description: | 100 TABLET in 1 BOX, UNIT-DOSE (0013-0101-11) |
NDC Code | 0013-0101-11 |
Proprietary Name | Azulfidine |
Package Description | 100 TABLET in 1 BOX, UNIT-DOSE (0013-0101-11) |
Product NDC | 0013-0101 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | SULFASALAZINE |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 19500620 |
Marketing Category Name | NDA |
Labeler Name | Pharmacia and Upjohn Company |
Substance Name | SULFASALAZINE |
Strength Number | 500 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Aminosalicylate [EPC],Aminosalicylic Acids [Chemical/Ingredient] |